Keywords: uk, launch, refludan, angina, filing, end-98, hoechst
UK Launch For Refludan; Angina Filing By End-98?
Article | 19 March 1998
Hoechst Marion Roussel's Refludan (lepirudin) has been launched in theUK, for the treatment of heparin-induced thrombocytopenia type II in patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
